actin-binding motif comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilised powder | Sealed vial; reconstituted before laboratory use |
| Appearance | White to off-white solid | Visual descriptor used on certificates of analysis |
| Solubility class | Water-soluble | Dissolves in water and aqueous buffers |
| Reported mass, fragment | Near 889 Da | Value depends on the stated sequence |
| Reported mass, parent protein | Near 4963 Da | 43-residue thymosin beta-4 |
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
=== Attribution === Portions of the text of this article originate from NIH Publication No. 02-4806, a public domain resource. "What I need to know about Prostate Problems". National Institutes of Health. 2002-06-01. No. 02-4806. Archived from the original on 2002-06-01. Retrieved 2011-01-24.
=== Seed === A fertilized lotus flower bears fruit that contains a cluster of 10 to 30 seeds. Each seed is ovoid 1–2.5 cm wide by 1–1.5 cm long with a brownish coat. Lotus seeds can remain viable after long periods of dormancy. In 1994, a seed from a sacred lotus, dated at roughly 1,300 years old ± 270 years, was successfully germinated. The genome of the sacred lotus was sequenced in May 2013. A dedicated genome database lists additional genome assemblies sequenced since then.
The concept of in situ in contemporary art developed in the late 1960s and 1970s, referring to works created for a specific site. Such works incorporate the site's physical, historical, political, and sociological characteristics as integral elements of their composition. This approach contrasts with autonomous artistic production, where artworks are conceived independently of their display location. Theoretical discussions, particularly in the writings and practice of French conceptual artist and sculptor Daniel Buren, have addressed the dynamic relationship between artistic intervention and its surrounding environment. The site-specific installations of Christo and Jeanne-Claude exemplify the application of in situ principles in art. Their large-scale interventions such as The Pont Neuf Wrapped (1985) and Wrapped Reichstag (1995) involved the systematic wrapping of buildings and landscape elements in fabric, temporarily transforming familiar spaces and altering public perception. Another example is the land art movement, wherein artists such as Robert Smithson and Michael Heizer integrated their works directly into natural landscapes. In contemporary aesthetic discourse, in situ describes practices that reinforce the fundamental unity between an artwork and its site.
== Detection and classification == Detection of drugs and pharmaceuticals in biological samples is usually done by an initial screening and then a confirmation of the compound(s), which may include a quantitation of the compound(s). The screening and confirmation are usually, but not necessarily, done with different analytical methods. Every analytical method used in forensic toxicology should be carefully tested by performing a validation of the method to ensure correct and indisputable results at all times. The choice of method for testing is highly dependent on what kind of substance one expects to find and the material on which the testing is performed. Customarily, a classification scheme is utilized that places poisons in categories such as: corrosive agents, gases and volatile agents, metallic poisons, non-volatile organic agents, and miscellaneous.
The Maronite Catholic and the Druze founded modern Lebanon in the early eighteenth century, through the ruling and social system known as the "Maronite-Druze dualism" in Mount Lebanon Mutasarrifate. Contact between Christians (members of the Maronite, Eastern Orthodox, Melkite, and other churches) and the Unitarian Druze led to the presence of mixed villages and towns in Mount Lebanon, Chouf, Wadi al-Taym, Jabal al-Druze, the Galilee region, Mount Carmel, and Golan Heights. They both speak the Arabic language and follow a social patterns similar to those of other peoples in the Levant (Eastern Mediterranean). Scholars classify Antiochian Greek Christians, Druze, and Maronites as ethnoreligious groups. The relationship between the Druze and Christians in Syria, Lebanon and Israel has been characterized by harmony and peaceful coexistence. Historically, they lived in the Chuf Mountains in complete harmony. On a social level, Druze and Christians have often interacted in daily life, sharing neighborhoods, schools, and workplaces. Druze and Christians in these regions celebrate each other's births, weddings, funerals, and celebrations such as Christmas, Maundy Thursday (in Lebanon), Easter and the Christian festival of Saint Elias (in Mount Carmel). Before 2011, more than 55,000 Christians lived in As-Suwayda Governorate, the only governorate in Syria with a Druze majority. In 2010, more than 52,000 registered Christian voters, primarily Maronites and Greek Orthodox, lived in the Aley District, where Druze constitute the majority.
Sources: en.wikipedia.org
The studies are progressively longer, gradually adding more individuals as they progress from stage I to stage III, normally over a period of years, and normally involve drug companies, the government and its laboratories, and often medical schools and hospitals and clinics. However, any exceptions to the aforementioned process are subject to strict review and scrutiny and conditions, and are only given if a substantial amount of research and at least some preliminary human testing has shown that they are believed to be somewhat safe and possibly effective. (See FDA Special Protocol Assessment about Phase III trials.)
Membrane-introduction mass spectrometry (MIMS) is a method of introducing analytes into the mass spectrometer's vacuum chamber via a semi-permeable membrane. Usually a thin, gas-permeable, hydrophobic membrane is used, for example polydimethylsiloxane. Samples can be almost any fluid including water, air or sometimes even solvents. The great advantage of the method of sample introduction is its simplicity. MIMS can be used to measure a variety of analytes in real-time, with little or no sample preparation. MIMS is most useful for the measurement of small, non-polar molecules, since molecules of this type have a greater affinity for the membrane material than the sample. The advantage of this method is that complex samples that cannot diffuse through the membrane are not incorporated into the mass spectroscopic measurements, highlighting the simplicity of only analyzing (small) molecules of interest.
== External links == Nutmeg - Erowid Nutmeg Reports - Erowid Experience Vaults - Erowid Nutmeg - PsychonautWiki The Big & Dandy Nutmeg Thread - Bluelight Myristicin - Isomer Design Myristica fragrans: An Exploration of the Narcotic Spice (2008) - Ibo Nagano - The Entheogen Review - Erowid
== Further reading == Merck Sharp and Dohme Corporation (22 May 2013). "Suvorexant Advisory Committee Meeting Briefing Document: Peripheral & Central Nervous System Drugs Advisory Committee Meeting" (PDF). Food and Drug Administration. Archived from the original (PDF) on 12 June 2013. Dimova H, Brar S, Men A (2014). "Application Number: 204569Orig1s000. Clinical Pharmacology/Biopharmaceutics Review. Suvorexant (MK-4305)" (PDF). Center for Drug Evaluation and Research (Food and Drug Administration). Archived from the original (PDF) on 5 March 2022.
Figures 1 and 2 show two-dimensional projections of a phase diagram. In the pressure-temperature phase diagram (Fig. 1) the boiling curve separates the gas and liquid region and ends in the critical point, where the liquid and gas phases disappear to become a single supercritical phase. The appearance of a single phase can also be observed in the density-pressure phase diagram for carbon dioxide (Fig. 2). At well below the critical temperature, e.g., 280 K, as the pressure increases, the gas compresses and eventually (at just over 40 bar) condenses into a much denser liquid, resulting in the discontinuity in the line (vertical dotted line). The system consists of 2 phases in equilibrium, a dense liquid and a low density gas. As the critical temperature is approached (300 K), the density of the gas at equilibrium becomes higher, and that of the liquid lower. At the critical point (304.1 K (31.0 °C; 87.7 °F) and 7.38 MPa (73.8 bar)), there is no difference in density, and the two phases become one fluid phase. Thus, above the critical temperature a gas cannot be liquefied by pressure. At slightly above the critical temperature (310 K), in the vicinity of the critical pressure, the line is almost vertical. A small increase in pressure causes a large increase in the density of the supercritical phase. Many other physical properties also show large gradients with pressure near the critical point, e.g. viscosity, the relative permittivity and the solvent strength, which are all closely related to the density.
Sources: en.wikipedia.org
=== Gas fill === Most modern bulbs are filled with an inert gas to reduce evaporation of the filament and prevent its oxidation. The gas is at a pressure of about 70 kPa (0.7 atm). The gas reduces evaporation of the filament, but the fill must be chosen carefully to avoid introducing significant heat losses. For these properties, chemical inertness and high atomic or molecular weight is desirable. The presence of gas keeps the tungsten below its vapor pressure, allowing it to be operated at higher temperature without reducing its life (or, for operating at the same temperature, prolongs the filament life). On the other hand, the presence of the gas leads to heat loss from the filament—and therefore efficiency loss due to reduced incandescence—by heat conduction and heat convection. Early lamps used only a vacuum to protect the filament from oxygen. The vacuum increases evaporation of the filament but eliminates two modes of heat loss. Some small modern lamps use vacuum as well. The most commonly used fills are:
Polymers display varying degrees of crystallinity, and many are completely non-crystalline. Glass, some ceramics, and many natural materials are amorphous, not possessing any long-range order in their atomic arrangements. The study of polymers combines elements of chemical and statistical thermodynamics to give thermodynamic and mechanical descriptions of physical properties.
=== WISeR Model (AI-assisted prior authorization in Original Medicare) === On January 1, 2026, CMS launched the Wasteful and Inappropriate Service Reduction (WISeR) Model through the Center for Medicare and Medicaid Innovation, introducing prior authorization for selected traditional Medicare Part B services in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. The model uses artificial intelligence to support medical necessity reviews, although all adverse determinations are made by licensed clinicians rather than automated systems. The model drew opposition from the American Hospital Association, which requested a six-month implementation delay, and prompted legislation introduced in late 2025 to repeal it.
=== Media coverage === Interest in Salvia divinorum escalated in the news media in the late 2000s, particularly in the United States, where an increasing number of newspaper reports have been published and television news stories broadcast. These stories generally raise alarms over salvia's legal status, for example comparing it to LSD, or describing it as "the new pot", with parental concerns being raised by particular focus on salvia's use by younger teens. Story headlines may also include 'danger' keywords, such as "Dangerous Herb is Legal..." or "Deadly Dangers Of A Street Legal High". Mainstream news coverage and journalistic opinion has widely been negative on the subject. In a local news report aired on ABC affiliate WJLA in Washington, DC on July 11, 2007, the anchors are seen to exchange expressions of incredulity when referring to a salvia story with the following introduction "Now, an exclusive I-Team investigation of a hallucinogenic drug that has begun to sweep the nation. What might amaze you is that right now the federal government is doing nothing to stop it." In March 2008, a Texas news report aired with the story "A legal drug that teenagers are now using to get high could soon be banned here in San Antonio - all because of a Fox News 4 investigation," going on to say, "The drug is legal in Texas, at least for now. But a News 4 investigation could lead to a new ordinance to protect your kids." Many salvia media stories headline with comparisons to LSD.
Sources: en.wikipedia.org
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.
Naming for research peptides is not standardised, and suppliers sometimes apply the same label to different chain lengths. Certificates of analysis and mass data are the practical way to determine what a given lot contains.
The fragment commonly cited under this label is reported near 889 Da, and the parent protein near 4963 Da. Reported values shift with the exact sequence and with residual counter-ions or water in the sample.
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.